In this webinar titled Artificial Intelligence (AI) 101 hosted by the National Society of Genetic Counselors welcomed guest speaker Dr.
Mark Kiel, co-founder and Chief Science Officer at Genomenon.
Attendees learned about the fundamentals of Artificial Intelligence and its implication in medical genomics—now and in the future.
- The distinction between narrow and general artificial intelligence, including a description of the
various subtypes of narrow AI from a non-technical perspective
- Examples of current and emerging technologies and their relevance to the genomic/precision
- An overview of the challenges to the adoption of AI in genomics
Learn more about the National Society of Genetic Counselors.
ABOUT THE SPEAKER:
Dr. Mark Kiel, Chief Science Officer – Genomenon
Mark Kiel completed his MD Ph.D. and Molecular Genetic Pathology Fellowship at the University of Michigan, where his research focused on stem cell biology, genomic profiling of hematopoietic malignancies, and clinical bioinformatics. He is the founder and CSO of Genomenon, where he supervises the scientific direction of the Mastermind suite of software tools.